Skip to main content

Randol Jamel Kennedy

Assistant Professor of Medicine
Medicine, Endocrinology, Metabolism, and Nutrition

Current Appointments & Affiliations


Assistant Professor of Medicine · 2025 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine

Recent Publications


Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.

Journal Article J Immunother Cancer · October 15, 2025 Immune checkpoint inhibitors (ICIs) are an important class of cancer treatment. Endocrine immune-related adverse events (E-irAEs) account for a significant proportion of irAEs in ICI-treated patients. Diagnosing E-irAEs accurately and timely can be challen ... Full text Link to item Cite

Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy.

Journal Article JCEM Case Rep · March 2025 Acquired generalized lipodystrophy (AGL) is rarely associated with immune checkpoint inhibitors (ICIs). A few cases report associations with inhibitors to programmed cell death protein 1 (PD-1 inhibitors); however, association with combined immunotherapies ... Full text Link to item Cite

Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.

Journal Article Endocr Pract · June 2024 OBJECTIVE: To provide a clinical approach towards immune checkpoint inhibitor (ICI)-associated endocrinopathies, their link with cancer outcomes, factors which differentiate them from other immune related adverse events, and health systems innovation to im ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


University of the West Indies, St. Augustine (Trinidad and Tobago) · 2012 M.B.B.S.